Clinical Trial Update: Spironolactone Plus Metformin in Polycystic Ovary Syndrome [NA]

View source ↗

Summary

Clinical trial update on the combination of spironolactone and metformin for polycystic ovary syndrome; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Spironolactone (spironolactone)
• metformin (metformin)

Snippet

Sponsor: University Magna Graecia | Conditions: Polycystic Ovary Syndrome | NA | Status: COMPLETED